BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33941395)

  • 1. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
    Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic analysis of patients with cherubism.
    Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
    Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib.
    Ricalde P; Ahson I; Schaefer ST
    J Oral Maxillofac Surg; 2019 Jun; 77(6):1278.e1-1278.e7. PubMed ID: 30880133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the SH3BP2 gene in 2 families of cherubism.
    Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
    Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cherubism Unmasked: A Case Report of Clinical and Histopathological Presentation.
    Akolkar S; Hande A; Sonone AM; Chavhan A; Tehzeeb H
    Cureus; 2024 Mar; 16(3):e56456. PubMed ID: 38638793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
    Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
    Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
    Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
    Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
    Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
    Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cherubism: best clinical practice.
    Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
    Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
    Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
    Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioid streaks and optic disc drusen in cherubism: a case report.
    Mello LGM; Saraiva FP; Monteiro MLR
    Arq Bras Oftalmol; 2020; 83(6):535-537. PubMed ID: 33470282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible case of cherubism in a 17th-century Korean mummy.
    Hershkovitz I; Spigelman M; Sarig R; Lim DS; Lee IS; Oh CS; May H; Boaretto E; Kim YS; Lee SD; Peled N; Kim MJ; Toledano T; Bar-Gal GK; Shin DH
    PLoS One; 2014; 9(8):e102441. PubMed ID: 25093864
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.